First patient enrolled in Sydney in worldwide prostate cancer trial
The first of 1,100 patients has been enrolled on a new cancer trial for treatment…
Browsing: darolutamide
FDA approves darolutamide for non-metastatic castration-resistant prostate cancer
The Food and Drug Administration (FDA) approved darolutamide for non-metastatic castration-resistant prostate cancer. Approval of…